Propranolol Hydrochloride Injection Shortage: Current Availability and Manufacturer Updates

Drug Shortages high FDA · · United States

The FDA reports a current shortage of Propranolol Hydrochloride Injection due to shipping delays, with the primary manufacturer reporting unavailability until March 2026.

What’s in Shortage

Propranolol Hydrochloride Injection (Brand Name: PROPRANOLOL) is currently listed in a shortage status. This medication is an injection within the Cardiovascular therapeutic category. The shortage specifically affects the 1 mg/1 mL dosage form.

Which Manufacturers Are Affected

According to the latest data, the following manufacturer is impacted:

  • Fresenius Kabi USA, LLC
    • Status: Unavailable
    • Presentation: Propranolol Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-604-01)
    • Notes: The next release is currently estimated for March 2026. The manufacturer suggests checking with wholesalers for any existing inventory.
    • Contact Information: 888-386-1300

Why There’s a Shortage

The reason provided for this shortage is a delay in shipping of the drug.

What Patients Should Do

If you or a loved one are prescribed Propranolol Hydrochloride Injection, please consider the following steps:

  1. Consult Your Healthcare Provider: Speak with your doctor immediately to discuss your treatment plan and any necessary clinical adjustments during this shortage.
  2. Contact Your Pharmacist: Inquire about current stock levels or if they can source the medication from alternative wholesalers.
  3. Contact the Manufacturer: You may use the contact information listed above to ask for updates regarding supply availability.

Disclaimer: This article is for informational purposes only. Patients should always consult their healthcare provider for medical advice and before making any changes to their medication regimen.

Source

This information is sourced from the FDA Drug Shortage Database.

  • Initial Posting Date: 10/31/2023
  • Last Updated: 02/05/2026

Source: FDA Official Notice